Ginette Serrero Selected Research

Therapeutics

5/2022	Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients.
1/2021	Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development.
1/2020	Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer.
5/2018	Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis.
1/2018	Measurement of Circulating Progranulin (PGRN/GP88/GEP) by Enzyme-Linked Immunosorbent Assay and Application in Human Diseases.
11/2016	Potential of Theranostic Target Mining in the Development of Novel Diagnostic and Therapeutic Products in Oncology: Progranulin/GP88 as a Therapeutic and Diagnostic Target for Breast and Lung Cancers.
2/2012	Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.
8/2003	Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ginette Serrero Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 01/2003
14	Carcinogenesis 11/2021 - 08/2003
14	Breast Neoplasms (Breast Cancer) 04/2021 - 08/2003
5	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 03/2009
4	Ductal Carcinoma 08/2016 - 07/2006
3	Neoplasm Metastasis (Metastasis) 03/2024 - 08/2003
3	Carcinoma (Carcinomatosis) 05/2018 - 05/2009
2	Frontotemporal Dementia (Semantic Dementia) 03/2024 - 01/2021
2	Inflammation (Inflammations) 01/2021 - 10/2017
2	Lymphoma (Lymphomas) 05/2018 - 10/2017
2	Multiple Myeloma 01/2006 - 06/2003
1	Hepatitis C 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 11/2021
1	Chronic Hepatitis C 11/2021
1	Triple Negative Breast Neoplasms 04/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Disease Progression 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 05/2018
1	Cognitive Dysfunction 05/2018
1	Multiple Sclerosis 01/2017
1	Neuromyelitis Optica (Devic's Disease) 01/2017
1	Lung Neoplasms (Lung Cancer) 11/2016
1	Osteoarthritis 10/2014
1	Rheumatoid Arthritis 10/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2014
1	Kidney Neoplasms (Kidney Cancer) 05/2009
1	Transitional Cell Carcinoma 05/2009
1	Glioblastoma (Glioblastoma Multiforme) 05/2009
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2009
1	Wounds and Injuries (Trauma) 03/2009
1	Adenocarcinoma 02/2004
1	Prostatic Intraepithelial Neoplasia 02/2004
1	Ovarian Neoplasms (Ovarian Cancer) 01/2003
1	Ovarian Epithelial Carcinoma 01/2003

Drug/Important Bio-Agent (IBA)

37	ProgranulinsIBA 03/2024 - 01/2003
13	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2021 - 01/2003
8	Glycoproteins (Glycoprotein)IBA 11/2021 - 09/2004
6	Biomarkers (Surrogate Marker)IBA 05/2022 - 03/2009
5	Proteins (Proteins, Gene)FDA Link 03/2024 - 12/2019
4	EnzymesIBA 11/2021 - 09/2014
4	Estrogens (Estrogen)FDA Link 11/2016 - 03/2004
4	Estrogen ReceptorsIBA 08/2016 - 03/2004
2	prostaglandin F2alpha receptorIBA 03/2024 - 01/2021
2	ParaffinIBA 01/2018 - 02/2012
2	Messenger RNA (mRNA)IBA 05/2009 - 03/2009
2	Tamoxifen FDA LinkGeneric 09/2004 - 03/2004
1	daclatasvirIBA 11/2021
1	asunaprevirIBA 11/2021
1	Antiviral Agents (Antivirals)IBA 11/2021
1	Protein Kinases (Protein Kinase)IBA 04/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	AntibodiesIBA 01/2021
1	SaporinsIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Extracellular Matrix ProteinsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 09/2020
1	Formaldehyde (Formol)FDA Link 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2014
1	ImmunosorbentsIBA 10/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2012
1	Aromatase InhibitorsIBA 06/2011
1	Letrozole (Femara)FDA LinkGeneric 06/2011
1	Aromatase (CYP19)IBA 06/2011
1	Mitogen-Activated Protein KinasesIBA 05/2009
1	Small Interfering RNA (siRNA)IBA 05/2009
1	AndrogensIBA 03/2009
1	Oncogene Proteins (Oncogene Protein)IBA 07/2006
1	Trastuzumab (Herceptin)FDA Link 07/2006
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2006
1	AgarIBA 01/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2004
1	Estradiol (Delestrogen)FDA LinkGeneric 03/2004
1	GranulinsIBA 01/2003
1	RNA (Ribonucleic Acid)IBA 01/2003

Therapy/Procedure

8	Therapeutics 05/2022 - 08/2003
1	Aftercare (After-Treatment) 11/2021
1	Drug Therapy (Chemotherapy) 11/2016
1	Precision Medicine 11/2016
1	Biological Therapy 11/2016